Canada Pension Plan Investment Board trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,323,003 shares of the healthcare conglomerate's stock after selling 9,836 shares during the quarter. UnitedHealth Group makes up about 2.1% of Canada Pension Plan Investment Board's portfolio, making the stock its 5th biggest holding. Canada Pension Plan Investment Board owned 0.47% of UnitedHealth Group worth $2,186,834,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also bought and sold shares of UNH. Western Pacific Wealth Management LP grew its holdings in shares of UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after purchasing an additional 19 shares in the last quarter. MCF Advisors LLC grew its position in UnitedHealth Group by 0.8% in the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock valued at $1,304,000 after purchasing an additional 20 shares during the period. Axiom Financial Strategies LLC raised its holdings in shares of UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after acquiring an additional 20 shares during the last quarter. Richwood Investment Advisors LLC boosted its holdings in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after acquiring an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC lifted its holdings in UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock worth $662,000 after acquiring an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Performance
NYSE:UNH traded down $128.94 on Friday, hitting $456.10. The stock had a trading volume of 29,048,929 shares, compared to its average volume of 4,373,443. The business's 50-day simple moving average is $512.95 and its two-hundred day simple moving average is $540.65. UnitedHealth Group Incorporated has a 52-week low of $438.50 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $417.20 billion, a price-to-earnings ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business earned $6.91 EPS. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.
Analysts Set New Price Targets
UNH has been the subject of several analyst reports. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Truist Financial upped their price target on shares of UnitedHealth Group from $610.00 to $660.00 and gave the company a "buy" rating in a research report on Friday, April 11th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Finally, StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Twenty-one equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $632.85.
Get Our Latest Report on UnitedHealth Group
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.